AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES…
Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 08, 2025 21:04 ET Â | Source: InnoCare Pharma BEIJING, Dec. 08,…
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9…
SEON Showcases AI-Powered Fraud Prevention and AML Innovations at Singapore FinTech Festival 2025; Company Executive to Present on Collaborative Cyber Resilience
SINGAPORE and AUSTIN, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SEON, the…
Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
October 24, 2025 07:02 ET Â | Source: Kura Oncology, Inc. - Milestone…
ArriTech Announces Its Next-Generation QGen Online Platform for No-Code, AI-Driven KYC, KYB, AML & Biometrics
FLORIANA, Malta, Sept. 30, 2025 /PRNewswire/ -- ArriTech today announced the next…
MoneyMe Selects SEON to Strengthen Fraud Prevention and Credit Decisioning
AUSTIN, Texas and SINGAPORE, Aug. 19, 2025 (GLOBE NEWSWIRE) -- SEON, the…
SEON Launches AI-Powered Anti-Money Laundering Suite, Enhancing its Comprehensive Command Center for Risk Management
AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- SEON, a global leader…